rs121918715
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3PP5_Moderate
The NM_003242.6(TGFBR2):c.1524G>A(p.Gln508Gln) variant causes a splice region, synonymous change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_003242.6 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Loeys-Dietz syndrome 2 Pathogenic:2
- -
TGFBR2 NM_001024847.2 exon7 p.Gln533Gln (c.1599G>A): This variant has been reported in the literature in 1 individual with clinical suspicion of Marfan/Loeys-Dietz syndrome (reported as Marfan Syndrome type 2), segregating with disease in 11 affected family members (reported as p.Gln508Gln, Mizguchi 2004 PMID:15235604). This variant is not present in large control databases. Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. Although this variant is "silent" and is not predicted to alter the amino acid, functional studies have indicated that this variant affects splicing (Mizguchi 2004 PMID:15235604). In summary, this variant is classified as pathogenic based on the data above (segregation studies, absence from controls, predicted impact to protein). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at